Posterior Spinal Correction and Fusion Surgery in Patients with Spinal Muscular Atrophy-Associated Scoliosis for Whom Treatment with Nusinersen Was Planned

INTRODUCTION: Spinal muscular atrophy (SMA) is defined as a neuromuscular disorder induced by progressive weakness of the skeletal muscle and is usually accompanied by progressive spinal deformity including scoliosis. The newly developed Nusinersen, which is the first approved drug worldwide for SMA...

Descripción completa

Detalles Bibliográficos
Autores principales: Machida, Shuhei, Miyagi, Masayuki, Saito, Wataru, Matsui, Ayano, Imura, Takayuki, Inoue, Gen, Nakazawa, Toshiyuki, Shirasawa, Eiki, Ikeda, Shinsuke, Kawakubo, Ayumu, Kuroda, Akiyoshi, Yokozeki, Yuji, Mimura, Yusuke, Uchida, Kentaro, Akazawa, Tsutomu, Takaso, Masashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society for Spine Surgery and Related Research 2020
Materias:
Technical Note
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8026202/
https://www.ncbi.nlm.nih.gov/pubmed/33842719
http://dx.doi.org/10.22603/ssrr.2020-0091

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8026202/
https://www.ncbi.nlm.nih.gov/pubmed/33842719
http://dx.doi.org/10.22603/ssrr.2020-0091

Ejemplares similares